quinapril (Q596022)

epi-ethoxycarbonyl quinapril

quinapril (English)

3 October 2016

2 references

inferred from InChIKey

inferred from InChI

epi-carboxy quinapril

1 reference

epi-carboxy epi-ethoxycarbonyl quinapril

inferred from InChI

1 reference

inferred from InChI

chemical formula

C₂₅H₃₀N₂O₅

1 reference

quinapril (English)

19 November 2016

CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O

1 reference

quinapril (English)

19 November 2016

CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O

1 reference

https://www.whocc.no/atc_ddd_index/?code=C09AA06

quinapril (English)

19 November 2016

15 milligram

route of administration

oral administration

1 reference

reference URL

15 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=C09AA06

1 reference

14 February 2018

World Health Organisation international non-proprietary name

quinapril (English)

1 reference

quinapril (English)

medical condition treated

3 October 2016

congestive heart failure

1 reference

13 December 2016

arterial hypertension

2 references

13 December 2016

Drug Indications Extracted from FAERS

significant drug interaction

2 October 2018

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimethoprim

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bromocriptine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bumetanide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

furosemide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bromocriptine

hyperinsulinism

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bumetanide

orthostatic hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

furosemide

orthostatic hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

LiverTox likelihood score

LiverTox toxicity likelihood category E*

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Quinapril

11 February 2018

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

C041125

15 March 2018

antihypertensive drug

1 reference

InChI=1S/C25H30N2O5/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30)/t17-,21-,22-/m0/s1

Medical Subject Headings

15 March 2018

Quinapril

0 references

Identifiers

InChI

1 reference

JSDRRTOADPPCHY-HSQYWUDLSA-N

quinapril (English)

19 November 2016

2 references

quinapril (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

85441-61-8

2 references

https://commonchemistry.cas.org/detail?cas_rn=85441-61-8

quinapril (English)

19 November 2016

6 April 2021

InChIKey

JSDRRTOADPPCHY-HSQYWUDLSA-N

1 reference

Korec (English)

19 November 2016

1 reference

quinapril (English)

19 November 2016

mapping relation type

1 reference

QUINAPRIL (English)

19 November 2016

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

QUINAPRIL (English)

19 November 2016

1 reference

DSSTOX compound identifier

0 references

0 references

1 reference

Guide to Pharmacology Ligand ID

Quinapril (English)

publication date

17 November 2015

6350

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

6350

quinapril (English)

19 November 2016

Quinapril

0 references

MeSH tree code

D03.633.100.531.820.250

0 references

0 references

1 reference

Quinapril (English)

Human Metabolome Database ID

19 November 2016

HMDB0015019

1 reference

inferred from InChIKey

1 reference

quinapril (English)

MedlinePlus drug identifier

19 November 2016

0 references

1 reference

quinapril (English)

19 November 2016

0 references

1 reference

1 reference

quinapril (English)

3 October 2016

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

quinapril (English)

3 October 2016

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

UMLS CUI

C0072857

1 reference